Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$582.5M
+41.0% from 2023
Prescriptions
60K
$9,713.94 per claim
Patients
7,187
3,145 prescribers
Total spending, 2024
$582.6M
$81,052.86 per patient
Medicare prescription drug plans paid $582.5M for Kesimpta Pen in 2024, for 59,963 prescriptions and refills to 7,187 patients (up 41.0% from 2023). The average cost per claim was $9,713.94.
Texas had the highest Medicare cost for Kesimpta Pen in 2024: $40.7M for 4,107 claims, followed by Florida ($37.9M).
Angel R Chinea Sr., neurology in Guaynabo, PR, had the highest Medicare cost for Kesimpta Pen in 2024: 530 claims costing $4.8M.
Kesimpta Pen is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Angel R Chinea Sr. Guaynabo, PR | Neurology | 530 | 54 | $4.8M |
| Nina S Bozinov Coeur D Alene, ID | Neurology | 438 | 51 | $3.7M |
| Sangjin Oh Glen Burnie, MD |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,786 | 24,062 | 3,416 | $233.3M |
| 2023 | 2,533 | 41,253 | 5,267 | $413.1M |
| 2024 | 3,145 | 59,963 | 7,187 | $582.5M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 277 |
| 33 |
| $2.8M |
| Dan Michael Pineda Burlington, MA | Neurology | 225 | 45 | $2.6M |
| Robert J Pace Owosso, MI | Neurology | 284 | 28 | $2.5M |
| Matthew T McAdams Burlington, MA | Neurology | 256 | 54 | $2.5M |
| Neil S Lava Atlanta, GA | Neurology | 246 | 32 | $2.2M |
| Esther Murray Wilmington, NC | Physician Assistant | 229 | 30 | $2.1M |
| Erik Burton Shreveport, LA | Neurology | 231 | 29 | $2.1M |
| Rahul H Dave Fairfax, VA | Neurology | 233 | 23 | $2.1M |
| Crystal M Wright Dallas, TX | Nurse Practitioner | 215 | 33 | $2.0M |
| Reinaldo D Verson Columbus, GA | Neurology | 215 | 27 | $2.0M |
| Patricia de Jesus Caguas, PR | Neurology | 215 | 24 | $2.0M |
| George J Hutton Houston, TX | Neurology | 197 | 22 | $1.9M |
| Joseph B Guarnaccia Derby, CT | Neurology | 194 | 28 | $1.9M |
| Jesus F Lovera New Orleans, LA | Neurology | 199 | 21 | $1.8M |
| James M Winkley II Lexington, KY | Neurology | 191 | 24 | $1.8M |
| Douglas Juvinall Peoria, IL | Neurology | 196 | 23 | $1.8M |
| Unsong Oh Richmond, VA | Neurology | 208 | 22 | $1.8M |
| Anna K Cluskey Milwaukee, WI | Physician Assistant | 195 | 21 | $1.8M |
| Maria Antonietta Mazzola Burlington, MA | Neurology | 169 | 32 | $1.8M |
| Mirela Cerghet Detroit, MI | Neurology | 194 | 23 | $1.8M |
| Michelle L Apperson Sacramento, CA | Neurology | 120 | 20 | $1.7M |
| Barry Singer Saint Louis, MO | Neurology | 184 | 22 | $1.7M |
| Shanan B Munoz Dallas, TX | Neurology | 164 | 25 | $1.7M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 59,976 | $582.6M |